Circulating miR-210 as a Novel Hypoxia Marker in Pancreatic Cancer - Wikidata - awgldk - TriplyDB

Circulating miR-210 as a Novel Hypoxia Marker in Pancreatic Cancer

Circulating miR-210 as a Novel Hypoxia Marker in Pancreatic Cancer

http://www.wikidata.org/entity/Q24609577

about

The autophagic tumor stroma model of cancer: Role of oxidative stress and ketone production in fueling tumor cell metabolism MiR-210--micromanager of the hypoxia pathway Liquid biopsy in patients with pancreatic cancer: Circulating tumor cells and cell-free nucleic acids The Role of microRNAs in the Diagnosis and Treatment of Pancreatic Adenocarcinoma Essential role of miRNAs in orchestrating the biology of the tumor microenvironment New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies MicroRNA in pancreatic ductal adenocarcinoma and its precursor lesions miRNAs As Diagnostic and Prognostic Biomarkers in Pancreatic Ductal Adenocarcinoma and Its Precursor Lesions: A Review Genome-wide analysis of microRNA and mRNA expression signatures in cancer Circulating RNAs as new biomarkers for detecting pancreatic cancer Use of miRNAs as biomarkers in sepsis Targeting CSCs in tumor microenvironment: the potential role of ROS-associated miRNAs in tumor aggressiveness Micro-RNAs as diagnostic or prognostic markers in human epithelial malignancies The circulating transcriptome as a source of non-invasive cancer biomarkers: concepts and controversies of non-coding and coding RNA in body fluids HypoxamiRs and cancer: from biology to targeted therapy Circulating microRNAs in cancer: origin, function and application MicroRNAs and long non-coding RNAs: prospects in diagnostics and therapy of cancer OxymiRs in cutaneous development, wound repair and regeneration MicroRNAs: promising new antiangiogenic targets in cancer miR-210: More than a silent player in hypoxia Tissue and serum microRNAs in the Kras(G12D) transgenic animal model and in patients with pancreatic cancer Origins, structures, and functions of circulating DNA in oncology Hypoxic enhancement of exosome release by breast cancer cells.Aberrant MicroRNAs in Pancreatic Cancer: Researches and Clinical Implications.Hypoxia-regulated MicroRNA-210 Overexpression is Associated with Tumor Development and Progression in Upper Tract Urothelial Carcinoma.Role of non-coding RNAs in pancreatic cancer: the bane of the microworld.Serum miRNA signature in Moyamoya disease.Improved blood tests for cancer screening: general or specific?MicroRNAs as emerging biomarkers and therapeutic targets for pancreatic cancer Serum microRNAs as biomarkers for hepatocellular carcinoma in Chinese patients with chronic hepatitis B virus infection.Noninvasive micromarkers An Argonaute 2 switch regulates circulating miR-210 to coordinate hypoxic adaptation across cells.Molecular mechanisms underlying the role of microRNAs in the chemoresistance of pancreatic cancer.Circulating microRNAs in Pancreatic Juice as Candidate Biomarkers of Pancreatic Cancer.Hypoxia induced aggressiveness of prostate cancer cells is linked with deregulated expression of VEGF, IL-6 and miRNAs that are attenuated by CDF.Serum microRNAs as non-invasive biomarkers for cancer.The molecular targets for the diagnosis and treatment of pancreatic cancer.MicroRNAs: Meta-controllers of gene expression in synaptic activity emerge as genetic and diagnostic markers of human disease MicroRNAs in Cancer Biology and Therapy: Current Status and Perspectives.Circulating miR-483-3p and miR-21 is highly expressed in plasma of pancreatic cancer

P2860

Q24611412-9D776BA5-53AC-4375-935C-94BC57EC3AC5 Q24628401-B4C7C2B8-2179-4AC6-ADD0-12FAF37F62FC Q26739062-C462A46A-C755-4B82-BCCA-79C8799050D4 Q26744298-177638C7-4184-49DC-834B-6FAB708E6979 Q26745667-0C042454-E530-4C8B-BC0A-A11970A6DDAB Q26748881-895B715F-4F82-460A-B217-F035B666F52B Q26769953-FE13691E-DB86-422E-9221-F5CE2BA5FBE5 Q26774628-12F932B8-A16E-4DE4-9E58-A36A5B0ED642 Q26795603-1D7B261C-96DB-4E53-8B3C-3590BD4B7E66 Q26801191-58E0FE08-4E1C-47EF-B231-113A17AE9EB8 Q26801909-F333FF54-8793-4013-A1E5-0CA0D89C63CA Q26822776-FE989FB0-21B5-4309-BECC-DB3213F6E774 Q26823077-5D6787A8-E8F3-4CF5-919E-ED5E72423A01 Q26825022-1B789879-7168-4BE8-BFC7-B9EDF93CB38E Q26863298-761D2D51-51A3-4F80-A527-CBADDBCCA5A9 Q27013716-872EBE59-3602-43DA-B54C-929FE22A60EF Q27022048-BC48D756-A595-47C6-9707-5211C9989203 Q27024906-75AF2A6D-4992-44D2-BCFD-341F43CC2B0C Q27027998-21E10E6E-A8AE-4D3F-96AF-FF749F347607 Q28306244-FF5F0100-FDAC-4F28-A00F-72ED4AEB9C6D Q28478758-02D719AD-FD07-4C7E-A3D8-96845272314A Q30249103-DBBC058F-141B-4370-A4EB-EB93DB027D98 Q30527905-B6A35C77-AB66-4182-91BE-6B9CB8118329 Q33668095-473C0ADE-9609-43B6-9986-C88019DB2F59 Q33820638-A4EE5E71-7761-488B-8472-EE592A15792B Q33948361-C40913C3-8612-4506-A59C-833599A7E983 Q34004659-BEDB665B-5FBD-408C-B8E2-DE4DACF5D0CF Q34086617-58E955CB-62FB-4333-80E4-1F6B8B705E48 Q34093798-AC0A4473-4B2B-470C-AF15-13FD9181F94B Q34103110-2831F935-EB07-4E25-A083-CA11D3E9A2B7 Q34111606-9BE2822F-D68C-47A3-8373-712ED204E684 Q34150859-F43A105F-3AC2-4562-8A96-1A70083CA14E Q34177065-C58D76DD-652D-4867-8D44-981DC30AD45A Q34241079-380F347A-12B4-4854-B49D-AB48869C6279 Q34405506-9B43CF0E-FD2B-4766-A5A4-EFD8632DA9FF Q34408233-3C19D059-D596-4373-984B-CBB6178DF3DD Q34494019-5FC12336-F4BC-41AE-A358-3BCC171FCD90 Q34594189-962C86ED-E874-4E15-8BAD-FDF283D68DF1 Q34599354-485A9708-6D7F-4F98-AD1C-8BCD09F8EA7E Q34775829-F94A82D6-7C8F-4E22-89DB-A5A990802741

P2860

Circulating miR-210 as a Novel Hypoxia Marker in Pancreatic Cancer

http://www.wikidata.org/entity/Q24609577

description

2010 nî lūn-bûn

@nan

2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Circulating miR-210 as a Novel Hypoxia Marker in Pancreatic Cancer

@ast

Circulating miR-210 as a Novel Hypoxia Marker in Pancreatic Cancer

@en

Circulating miR-210 as a Novel Hypoxia Marker in Pancreatic Cancer

@nl

type

label

Circulating miR-210 as a Novel Hypoxia Marker in Pancreatic Cancer

@ast

Circulating miR-210 as a Novel Hypoxia Marker in Pancreatic Cancer

@en

Circulating miR-210 as a Novel Hypoxia Marker in Pancreatic Cancer

@nl

prefLabel

Circulating miR-210 as a Novel Hypoxia Marker in Pancreatic Cancer

@ast

Circulating miR-210 as a Novel Hypoxia Marker in Pancreatic Cancer

@en

Circulating miR-210 as a Novel Hypoxia Marker in Pancreatic Cancer

@nl

P1433

Q24609577-7FD7B4D1-1161-489E-95A9-A1A7FBD78D0A

P1476

Q24609577-168ADDD9-3C48-44E8-92B4-C6D8328194AB

P2093

Q24609577-11B786B6-DC64-45CC-86BD-FB52512E48CF

Q24609577-1355E9F1-841A-4198-A9FC-D001E0DA09E3

Q24609577-51D2F557-DD94-420D-A9AA-4C888AD2F880

Q24609577-7C8BB23F-2D6B-4F8A-A00F-94D994A5ECD5

Q24609577-A476B1E6-4EBD-4251-9F33-B47E2251888A

Q24609577-D2EBFC42-13FA-4088-A5F2-94531606E4C5

Q24609577-F2CA0F45-0D1E-4845-91E7-A90F58344C27

P2860

Q24609577-1400A8F9-E6CC-4FB0-A2F7-AB461046C40C

Q24609577-1C8A2E04-86F0-4936-85B7-45C2170DC483

Q24609577-32E77421-C62C-42ED-AB63-1606F2ACACE2

Q24609577-365571B2-8B4D-4771-A505-72CBB1E131A6

Q24609577-41B0A3E6-47D5-4CA0-A8C1-2C4E5182F012

Q24609577-4FFB0EC8-CF6D-4877-9E4E-17B40BA928EC

Q24609577-5D7486F5-4704-4C07-BD43-DF4E7E1ADD32

Q24609577-6291F626-4F59-498D-9075-7A2527EB8149

Q24609577-8D8BA636-843C-47F9-B83E-B89A3DA13273

Q24609577-93124300-D2EA-4319-8B4B-E5C95BDF545C

P304

Q24609577-71C99D89-7652-4F51-B645-67543AA0D06D

P31

Q24609577-EFBD30AE-E2F8-47B1-AD8A-435EE910C941

P3181

Q24609577-AB71AF0C-E26A-4A1C-9B5A-D321C1F0DAD4

P356

Q24609577-571C1CC0-FF8C-4AA2-B612-86E0E702DD2E

P407

Q24609577-12B35428-E70B-4A52-9EA8-636A05C02EA3

P433

Q24609577-74CF2040-1FE2-49AF-AA0C-A2D7094C2B42

P478

Q24609577-52128C43-E677-40B4-AFC2-88F6DC13CDBD

P577

Q24609577-49D7C8B8-155B-4300-950A-4FFC5D280B99

P5875

Q24609577-65F69D73-1CCA-4867-9E6B-A9E44631A2FE

P698

Q24609577-DB4E9146-ACF7-456F-BBF5-2554741C09DD

P921

Q24609577-FFD3D5DC-C44B-4D66-B10C-904F6497BD18

P932

Q24609577-1B2D82EB-5A48-418D-881A-12B7864143A0

P3181

P356

P1433

Translational Oncology

P1476

Circulating miR-210 as a Novel Hypoxia Marker in Pancreatic Cancer

@en

P2093

Albert C Koong

http://www.w3.org/2001/XMLSchema#string

Allen S Ho

http://www.w3.org/2001/XMLSchema#string

Claudia Christman-Skieller

http://www.w3.org/2001/XMLSchema#string

Hongbin Cao

http://www.w3.org/2001/XMLSchema#string

Kevin Bennewith

http://www.w3.org/2001/XMLSchema#string

Quynh-Thu Le

http://www.w3.org/2001/XMLSchema#string

Xin Huang

http://www.w3.org/2001/XMLSchema#string

P2860

miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer

Hypoxia-inducible mir-210 regulates normoxic gene expression involved in tumor initiation.

Circulating microRNAs as stable blood-based markers for cancer detection.

A microRNA signature of hypoxia

Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases

MicroRNA regulation of DNA repair gene expression in hypoxic stress

Cancer statistics, 2009

Diagnosis and management of skin resurfacing-related complications.

hsa-miR-210 Is induced by hypoxia and is an independent prognostic factor in breast cancer.

MicroRNA: implications for cancer.

P304

109-13

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

741664

http://www.w3.org/2001/XMLSchema#string

P356

10.1593/TLO.09256

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2010-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

42834137

http://www.w3.org/2001/XMLSchema#string

P698

20360935

http://www.w3.org/2001/XMLSchema#string

P921

P932

2847318

http://www.w3.org/2001/XMLSchema#string